Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter Jeske

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|April 15, 2024
Syndecan-1 Level, a Marker of Endothelial Glycocalyx Degradation, Is Associated With Fetal Exposure to Chorioamnionitis and Is a Potential Biomarker for Early-Onset Neonatal SepsisMichaela O'Neil, Sasha K Demeulenaere, Phillip J DeChristopher, et al.
Journal of Vascular Surgery|December 13, 2016
Synthetic, organic compound vepoloxamer (P-188) potentiates tissue plasminogen activatorDaniel Dansdill, Pegge M Halandras, Joshua Beverly, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 13, 2023
Potency Adjusted Blended Heparin of Bovine, Ovine, and Porcine Heparin Exhibit Comparable Biologic Effects to Referenced Single-Sourced Porcine HeparinGuy Olson, Walter Jeske, Omer Iqbal, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 20, 2003
Global anticoagulant effects of a synthetic anti-factor Xa inhibitor (DX-9065a): implications for interventional useMahmut Tobu, Omer Iqbal, Qing Ma, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 10, 2020
Assay-Based Differentiation in the Neutralization Profile of Unfractionated Heparin, Enoxaparin, and Fondaparinux by Andexanet AlfaFakiha Siddiqui, Alfonso Tafur, Emily Bontekoe, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 21, 2009
Isolation and characterization of contaminants in recalled unfractionated heparin and low-molecular-weight heparinChristian Viskov, E Bouley, P Hubert, et al.
Pediatric Research|June 4, 2019
ABO blood group and procoagulant factors: the hypercoagulation hypothesis ABO and Procoagulant FactorsAngela Lai, Walter Jeske, Omar Habeeb, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|August 26, 2009
Comparative anticoagulant and platelet modulatory effects of enoxaparin and sulodexideCafer Adiguzel, Omer Iqbal, Debra Hoppensteadt, et al.
Journal of Pediatric Surgery|February 18, 2014
The relationship between reticulated platelets, intestinal alkaline phosphatase, and necrotizing enterocolitisRichard Kampanatkosol, Tricia Thomson, Omar Habeeb, et al.
Carbohydrate Polymers|April 7, 2023
Absolute pharmacokinetics of heparin in primatesYuefan Song, Ahmed Kouta, Lee M Cera, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|April 15, 2024
Syndecan-1 Level, a Marker of Endothelial Glycocalyx Degradation, Is Associated With Fetal Exposure to Chorioamnionitis and Is a Potential Biomarker for Early-Onset Neonatal SepsisMichaela O'Neil, Sasha K Demeulenaere, Phillip J DeChristopher, et al.
Journal of Vascular Surgery|December 13, 2016
Synthetic, organic compound vepoloxamer (P-188) potentiates tissue plasminogen activatorDaniel Dansdill, Pegge M Halandras, Joshua Beverly, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 13, 2023
Potency Adjusted Blended Heparin of Bovine, Ovine, and Porcine Heparin Exhibit Comparable Biologic Effects to Referenced Single-Sourced Porcine HeparinGuy Olson, Walter Jeske, Omer Iqbal, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 20, 2003
Global anticoagulant effects of a synthetic anti-factor Xa inhibitor (DX-9065a): implications for interventional useMahmut Tobu, Omer Iqbal, Qing Ma, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 10, 2020
Assay-Based Differentiation in the Neutralization Profile of Unfractionated Heparin, Enoxaparin, and Fondaparinux by Andexanet AlfaFakiha Siddiqui, Alfonso Tafur, Emily Bontekoe, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 21, 2009
Isolation and characterization of contaminants in recalled unfractionated heparin and low-molecular-weight heparinChristian Viskov, E Bouley, P Hubert, et al.
Pediatric Research|June 4, 2019
ABO blood group and procoagulant factors: the hypercoagulation hypothesis ABO and Procoagulant FactorsAngela Lai, Walter Jeske, Omar Habeeb, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|August 26, 2009
Comparative anticoagulant and platelet modulatory effects of enoxaparin and sulodexideCafer Adiguzel, Omer Iqbal, Debra Hoppensteadt, et al.
Journal of Pediatric Surgery|February 18, 2014
The relationship between reticulated platelets, intestinal alkaline phosphatase, and necrotizing enterocolitisRichard Kampanatkosol, Tricia Thomson, Omar Habeeb, et al.
Carbohydrate Polymers|April 7, 2023
Absolute pharmacokinetics of heparin in primatesYuefan Song, Ahmed Kouta, Lee M Cera, et al.
Pageof 7